Lunchtime session
Asthma: emerging risk factors and current management of the patient
Clinical
Joint ERS/Lancet session
Aims : To learn about the latest treatments, clinical developments and thinking in the areas of asthma risk, management and treatment.
Chairs
I. Pavord
Oxford (Oxfordshire)
(United Kingdom)
13:00
Known and emerging risk factors for asthma development: is prevention possible?
R. Beasley(Wellington, New Zealand)
COI
1
2810
13:20
Targeting the interleukin pathway in the treatment of asthma
K. Chung(London, United Kingdom)
COI
2
2811
13:40
Novel insights into the genetics of smoking behaviour, lung function and chronic obstructive pulmonary disease in UK Biobank
I. Hall(Nottingham (Nottinghamshire), United Kingdom)
COI
3
2812
14:00
Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo controlled, phase 2b trial
C. Brightling(Leicester (Leicestershire), United Kingdom)
COI
4
2813
. . .
